Calpain activation has been implicated in the development of
ischemia-reperfusion (I-R) injury. Here we investigate the effects of two inhibitors of
calpain activity,
PD150606 and
E-64, on the renal dysfunction and injury caused by I-R of rat kidneys in vivo. Male Wistar rats were administered
PD150606 or
E-64 (3mg/kg i.p.) or vehicle (10%, v/v,
DMSO) 30min prior to I-R. Rats were subjected to bilateral renal
ischemia (45min) followed by reperfusion (6h). Serum and urinary biochemical indicators of renal dysfunction and injury were measured; serum
creatinine (for glomerular dysfunction), fractional excretion of Na(+) (FE(Na), for tubular dysfunction) and urinary
N-acetyl-beta-d-glucosaminidase (NAG, for tubular injury). Additionally, kidney tissues were used for histological analysis of renal injury, immunohistochemical analysis of
intercellular adhesion molecule-1 (ICAM-1) expression and
nitrotyrosine formation. Renal
myeloperoxidase (MPO) activity (for polymorphonuclear leukocyte infiltration) and
malondialdehyde (MDA) levels (for tissue lipid peroxidation) were determined. Both
PD150606 and
E-64 significantly reduced the increases in serum
creatinine, FE(Na) and NAG caused by renal I-R, indicating attenuation of renal dysfunction and injury and reduced histological evidence of renal damage caused by I-R. Both
PD150606 and
E-64 markedly reduced the evidence of oxidative stress (ICAM-1 expression, MPO activity, MDA levels) and nitrosative stress (
nitrotyrosine formation) in rat kidneys subjected to I-R. These findings provide the first evidence that
calpain inhibitors can reduce the renal dysfunction and injury caused by I-R of the kidney and may be useful in enhancing the tolerance of the kidney against renal injury associated with aortovascular surgery or
renal transplantation.